Evidence map›Paper›PMID 41801809›Full record

ArticleJournal of visualized experiments : JoVE2026

Rapid Production of Recombinant Human SLFN14 Ribonuclease and Stoichiometric Analysis by Mass Photometry.

Cole D Masuga, Justin Van Riper, Monica C Pillon

Abstract readVideo-Audio Media
In one paragraph

Article in Journal of visualized experiments : JoVE, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Cole D MasugaDepartment of Structural Biology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, SUNY.
Justin Van RiperVerna and Marrs McLean Department of Biochemistry and Molecular Pharmacology, Baylor College of Medicine; Therapeutic Innovation Center (THINC), Baylor College of Medicine.
Monica C PillonDepartment of Structural Biology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, SUNY; mpillon@buffalo.edu.

Funding

New Mechanisms of the Pseudouridine Synthase Module in Mitoribosome AssemblyR35GM147123 · NIGMS · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI Monica Pillon · 2022 to 2026
$2.0M
Research and Career Training for Cellular, Biochemical and Molecular ScientistsT32GM159557 · NIGMS · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI Melissa R McCartney, Christine E Schaner-Tooley · 2025 to 2026
$429k
NIGMS NIH HHS R35 GM147123NIGMS NIH HHS T32 GM159557
6 · The paper itself

Abstract

Ribonucleases are a specialized class of RNA binding proteins that catalyze RNA cleavage and contribute to diverse biological processes including gene regulation. Nevertheless, the structure, function, and regulation of many human ribonucleases remain poorly characterized due to the challenges of recombinant protein production. This method describes an efficient approach for the transient expression, purification, and stoichiometric analysis of the human Schlafen 14 (SLFN14) ribonuclease. Recombinant Flag-tagged SLFN14 was expressed in HEK293 suspension cells and isolated using a rapid two-step purification workflow consisting of anti-Flag affinity chromatography followed by low-resolution size exclusion chromatography. Mass photometry, a sensitive single-molecule technique, revealed that in physiological salt conditions SLFN14 forms a stable homodimer bound to cellular RNA, whereas high salt promotes RNA dissociation while preserving the homodimer arrangement. The resulting recombinant human SLFN14 protein is suitable for downstream structural studies and qualitative biochemical assays. This rapid approach for recombinant human protein isolation and sample characterization is broadly applicable for the production of other mammalian ribonucleases and RNA binding proteins intended for biophysical and biochemical characterization.

Indexed as

Mass SpectrometryNuclear ProteinsRibonucleasesChromatography, AffinityHEK293 CellsHumansRecombinant ProteinsRNANuclear ProteinsRecombinant ProteinsRibonucleasesRNA

Identifiers

PMID41801809
PMCPMC13247871

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.